Service agreement coverage for novocyte quanteon flow cytometer system and xcelligence rtca cardioecr instrument.
Ended Purchase Order Awarded Last action
- Contract number
- 75N95020P00235
- Awardee
-
Acea Biosciences, Inc. UEI KDBTPQNGNYH5 Part of Agilent Technologies, Inc.
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,988
Award facts
- Opportunity
-
- 75N950Q00104 Solicitation number
- Contract value 100% obligated
- $4,987.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$14,963 | |
| Funding Only Action | -$18,810 | |
| Original award | $38,760 |
About this award
This federal contract award was made by the National Institute on Drug Abuse, a civilian agency, to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The $4,987.50 firm fixed-price purchase order is for service agreement coverage of a NovoCyte Quanteon flow cytometer system and an xCELLigence RTCA CardioECR instrument. The award does not have a set-aside designation, indicating it was competed on a full and open basis. Acea Biosciences has received numerous prior federal contract awards from various agencies to provide specialized laboratory equipment, instruments, and related services to support scientific research efforts, demonstrating their capabilities in this domain. This contract award will enable the National Institute on Drug Abuse to maintain and service the critical flow cytometry and cell analysis instrumentation used in their research programs.
Quick answers
Who was awarded contract 75N95020P00235?
75N95020P00235 was awarded to Acea Biosciences, Inc. by National Institute on Drug Abuse (National Institutes of Health) on June 3, 2020.
How much is contract 75N95020P00235 worth?
The government has obligated $4,988 on 75N95020P00235.
Was contract 75N95020P00235 competed?
The extent of competition for 75N95020P00235 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award